Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 10, 2006 10:32 ET | Source: Brevard Music Center

Leading Music Center Hosts First Conference on Music Entrepreneurship

Conference Helps Turn Musicians Into Entrepreneurs Addresses Urgent Need for Alternative Career Tracks in Music BREVARD, N.C., May 10, 2006 (PRIMEZONE) -- With a career in music...
May 10, 2006 10:12 ET | Source: Kiwa Bio-Tech Products Group Corporation

Kiwa Bio-Tech to Acquire Beijing Huasheng Medicine Co.

CLAREMONT, Calif., May 10, 2006 (PRIMEZONE) -- Kiwa Bio-Tech Products Group Corporation (OTCBB:KWBT) reported today that it has signed an agreement to acquire 60% of the shares of Beijing Huasheng...
May 10, 2006 08:59 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: Director/PDMR Shareholding

BAGSVAERD, Denmark, May 10, 2006 (PRIMEZONE) -- In accordance with Section 28a of the Danish Securities Trading Act, Novo Nordisk is required on a daily basis to publish trading in Novo Nordisk shares...
May 10, 2006 08:31 ET | Source: Novo Nordisk A/S

Director/PDMR Shareholding

In accordance with Section 28a of the Danish Securities Trading Act, Novo Nordisk is required on a daily basis to publish trading in Novo Nordisk shares by the company's board members, executives and...
May 10, 2006 02:00 ET | Source: UCB

UCB et Immunomedics annoncent un accord de licence et collaboration en matière de développement mondial de Epratuzumab

Morris Plains, New Jersey (U.S.A.) et Bruxelles, Belgique, le 10 mai 2006 - UCB (Euronext Bruxelles : UCB), une société biopharmaceutique leader sur le marché mondial et Immunomedics, Inc....
May 10, 2006 02:00 ET | Source: UCB

UCB and Immunomedics announce worldwide development collaboration and license agreement for Epratuzumab

Brussels, Belgium and Morris Plains, New Jersey, May 10, 2006 - UCB (Euronext Brussels: UCB), a leading global biopharmaceutical company, and Immunomedics, Inc. (Nasdaq: IMMU), a biopharmaceutical...
May 10, 2006 02:00 ET | Source: UCB

UCB en Immunomedics kondigen wereldwijde ontwikkelingssamenwerking en licentieovereenkomst voor Epratuzumab aan

Morris Plains, New Jersey, VS en Brussel, België, 10 mei 2006 - UCB (Euronext Brussel: UCB), een toonaangevend globaal biofarmaceutisch bedrijf en Immunomedics, Inc. (Nasdaq: IMMU), een...
May 10, 2006 02:00 ET | Source: Wolters Kluwer Global Brand B.V.

Wolters Kluwer First-Quarter 2006 Results

Highlights for the first quarter of 2006 include: - Revenues of €854 million, a 14% increase over first quarter 2005 (€746 million); organic revenues grew 1%; contribution of acquisitions was...
May 09, 2006 17:45 ET | Source: Nicholas-Applegate Convertible & Income Fund

Nicholas-Applegate Convertible & Income Fund Reports Results for the Fiscal Quarter and Year Ended February 28, 2006

NEW YORK, May 9, 2006 (PRIMEZONE) -- Nicholas-Applegate Convertible & Income Fund (the "Fund") (NYSE:NCV), a closed-end management investment company which seeks to provide total return through a...
May 09, 2006 16:05 ET | Source: Medicis Pharmaceutical Corporation

Medicis Reports First Quarter 2006 Financial Results

SCOTTSDALE, Ariz., May 9, 2006 (PRIMEZONE) -- Medicis (NYSE:MRX) today announced revenue for the three months ended March 31, 2006 of approximately $75.2 million with "if-converted" net income of...